CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Clinical trial NCT03774654 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03774654
Sponsor: Baylor College of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory B-Cell Non-Hodgkin Lymphoma Refractory B-Cell Small Lymphocytic Lymphoma Relapsed Adult ALL Relapsed CLL Relapsed Non Hodgkin Lymphoma

Start date: 2020-04-14
Primary completion: 2025-06-05
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.